
Commentary|Articles|November 21, 2025
AJMC® in the Press, November 21, 2025
Author(s)Julia Bonavitacola
Fact checked by: Maggie L. Shaw
Listen
0:00 / 0:00
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
An article from
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer
3
Atacicept Becomes First BAFF/APRIL Inhibitor Approved for IgA Nephropathy: Richard Lafayette, MD
4
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
5




